CHARLOTTESVILLE, Va., May 3, 2012 /PRNewswire/ -- ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced it has entered into a non-exclusive agreement with TATAA Biocenter for distribution of ZyGEM's DNA and RNA extraction products in Sweden and other selected countries worldwide. TATAA Biocenter is a leading provider of quantitative real-time PCR (qPCR) services and products. This new agreement is the latest in a series of distribution agreements for ZyGEM's DNA and RNA extraction kits with life science distributors globally.
ZyGEM's line of nucleic acid extraction kits feature optimized formulations of proprietary enzymatic technologies that use a single-tube process to provide complete extraction of high quality DNA or RNA from specific sample types rapidly and cost effectively. Its prepGEM™, forensicGEM™, livestockGEM™ and RNAGEM™ family of products enables nucleic acid extraction from diverse sample types for human and animal DNA and RNA testing.
"We are very pleased to be partnering with qPCR pioneer TATAA Biocenter to expand the availability of our DNA and RNA extraction products," said Paul Kinnon, CEO of ZyGEM. "TATAA is synonymous with excellence in qPCR, and this agreement is another example of our strategy of working with diverse partners to bring the advantages of our nucleic acid extraction technologies to researchers worldwide."
Founded in 2001 by pioneers in quantitative PCR, TATAA Biocenter is Europe's leading provider of gene expression profiling services and a prime organizer of training in qPCR and other molecular techniques to quant
|SOURCE ZyGEM Corp. Ltd.|
Copyright©2010 PR Newswire.
All rights reserved